Does VFEND IV Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- MISC ANTIFUNGAL AGENTS/ASTEMIZOLE; TERFENADINE
- ISAVUCONAZONIUM; VORICONAZOLE/SELECTED CYP3A4 INDUCERS
- VORICONAZOLE/EFAVIRENZ-EMTRICITABINE-TENOFOVIR
- VORICONAZOLE/NATISEDINE (COMBO OF QUINIDINE & PHENOBARBITAL)
- STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RANOLAZINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVABRADINE
- STRONG CYP3A4 INHIBITORS/UBROGEPANT
- SELECTED STRONG CYP3A4 INHIBITORS/TRIAZOLAM
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
- STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (> 50 MG)
- STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- SELECTED STRONG CYP3A4 INHIBITORS/ISAVUCONAZONIUM
- STRONG CYP3A4 INHIBITORS/PANOBINOSTAT (> 10 MG)
- STRONG CYP3A4 INHIBITORS/NALOXEGOL
- STRONG CYP3A4 INHIBITORS/AVANAFIL
- 3A4INHIB/DAPOXETINE;LEVOMILNACIPRAN(>80MG);VILAZODONE(>20MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
- SELECTED STRONG CYP3A4 INHIBITORS/DOMPERIDONE; CISAPRIDE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/TICAGRELOR
- SELECTED AZOLE ANTIFUNGAL AGENTS/LURASIDONE
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/DRONEDARONE
- STRONG CYP3A4 INHIBITORS/CONIVAPTAN; TOLVAPTAN
- VORICONAZOLE/LOVASTATIN; SIMVASTATIN
- STRONG CYP3A4 INHIBITORS/ALFUZOSIN; SILODOSIN; TAMSULOSIN
- STRONG CYP3A4 INHIBITORS/EPLERENONE
- STRONG CYP3A4 INHIBITORS/IRINOTECAN
- POSACONAZOLE; VORICONAZOLE/ERGOT ALKALOIDS
- SELECTED AZOLE ANTIFUNGALS/ELETRIPTAN
- SELECTED AZOLE ANTIFUNGALS/DISOPYRAMIDE; QUINIDINE
- SELECTED AZOLE ANTIFUNGALS/PIMOZIDE
- STRONG CYP3A4 INHIBITORS/VARDENAFIL (>2.5 MG)
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECT AZOLE ANTIFUNGAL AGENTS/COUMARIN ANTICOAGULANTS
- VORICONAZOLE/COBICISTAT; RITONAVIR
- VORICONAZOLE/EFAVIRENZ
- VORICONAZOLE/DARUNAVIR; LOPINAVIR
- VORICONAZOLE/FLUCONAZOLE
- VORICONAZOLE/LETERMOVIR
- VORICONAZOLE/PHENYTOIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/TOREMIFENE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SUNITINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PAZOPANIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/NILOTINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LAPATINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/DASATINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CRIZOTINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CERITINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/BOSUTINIB
- STRONG CYP3A4 INHIBITORS/VINFLUNINE
- STRONG CYP3A4 INHIBITORS/VINCRISTINE
- STRONG CYP3A4 INHIBITORS/VINBLASTINE
- STRONG CYP3A4 INHIBITORS/TOFACITINIB
- STRONG CYP3A4 INHIBITORS/SONIDEGIB
- STRONG CYP3A4 INHIBITORS/RUXOLITINIB
- STRONG CYP3A4 INHIBITORS/PONATINIB
- STRONG CYP3A4 INHIBITORS/PALBOCICLIB
- STRONG CYP3A4 INHIBITORS/PACLITAXEL
- STRONG CYP3A4 INHIBITORS/OLAPARIB
- STRONG CYP3A4 INHIBITORS/IXABEPILONE
- STRONG CYP3A4 INHIBITORS/IDELALISIB
- STRONG CYP3A4 INHIBITORS/ERLOTINIB
- STRONG CYP3A4 INHIBITORS/DOXORUBICIN
- STRONG CYP3A4 INHIBITORS/DOCETAXEL
- STRONG CYP3A4 INHIBITORS/DABRAFENIB
- STRONG CYP3A4 INHIBITORS/COBIMETINIB
- STRONG CYP3A4 INHIBITORS/CABOZANTINIB
- STRONG CYP3A4 INHIBITORS/CABAZITAXEL
- STRONG CYP3A4 INHIBITORS/AXITINIB
- STRONG CYP3A4 INHIBITORS/SUVOREXANT
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVOSIDENIB
- STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/VEMURAFENIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/LURBINECTEDIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUETIAPINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SELPERCATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/OSILODROSTAT
- STRONG CYP3A4 INHIBITORS/RIMEGEPANT
- STRONG CYP3A4 INHIBITORS/NIMODIPINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ROMIDEPSIN
- STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
- STRONG CYP3A4 INHIBITORS/AVAPRITINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/LUMATEPERONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- STRONG CYP3A4 INHIBITORS; FLUCONAZOLE/VOXELOTOR
- POSSIBLE QT PROLONGING AGENTS/HYDROXYCHLOROQUINE
- STRONG CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIBITORS/NALDEMEDINE
- STRONG CYP3A4 INHIBITORS/ISTRADEFYLLINE
- VORICONAZOLE/FEDRATINIB
- SELECTED STRONG CYP3A4 INHIBITORS/ORAL LEFAMULIN
- STRONG CYP3A4 INHIBITORS/FEDRATINIB
- STRONG CYP3A4 INHIBITORS/ENTRECTINIB
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB
- STRONG CYP3A4 INHIBITORS/LAROTRECTINIB
- STRONG CYP3A4 INHIBITORS/GLASDEGIB
- STRONG CYP3A4 INHIBITORS/LORLATINIB
- STRONG CYP3A4 INHIBITORS/DUVELISIB
- STRONG CYP3A4 INHIBITORS/ELAGOLIX
- STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- STRONG AND MODERATE CYP3A4 INHIBITORS/ENCORAFENIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- POSACONAZOLE; VORICONAZOLE/IBRUTINIB
- STRONG CYP3A4 INHIBITORS/ACALABRUTINIB
- STRONG CYP3A4 INHIBITORS/ABEMACICLIB
- STRONG CYP3A4 INHIBITORS/COPANLISIB
- STRONG CYP3A4 INHIB;MODERATE 3A4 & P-GP DUAL INHIB/NERATINIB
- STRONG CYP3A4 INHIBITORS/BRIGATINIB
- STRONG CYP3A4 INHIBITORS/VALBENAZINE
- STRONG CYP3A4 INHIBITORS/RIBOCICLIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- SLT STRONG 3A4 INHIBITORS/SILDENAFIL (PAH); TADALAFIL (PAH)
- STRONG CYP3A4 INHIBITORS/PIMAVANSERIN
- STRONG CYP3A4 INHIBITORS/VENETOCLAX
- STRONG CYP3A4 INHIBITORS/TRABECTEDIN
- STRONG CYP3A4 INHIBITORS/CARIPRAZINE
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/BEDAQUILINE;DELAMANID
- STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
- STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
- STRONG CYP3A4 INHIBITORS/DACLATASVIR
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- STRONG CYP3A4 INHIBITORS/VORAPAXAR
- POSSIBLE QT PROLONGING AGENTS/ANAGRELIDE
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- POSACONAZOLE; VORICONAZOLE/SELECTED IMMUNOSUPPRESSANTS
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- STRONG CYP3A4 INHIBITORS/MACITENTAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/BOSENTAN
- FLUCONAZOLE; VORICONAZOLE/OSPEMIFENE
- FLUCONAZOLE; VORICONAZOLE/LEVOMETHADONE; METHADONE
- STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR/MIFEPRISTONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
- SELECT CYP2C19 INHIBITORS/CITALOPRAM (>20 MG)
- FLUCONAZOLE; KETOCONAZOLE; VORICONAZOLE/CLOPIDOGREL
- POSSIBLE QT PROLONGING AGENTS/ARTEMETHER-LUMEFANTRINE
- STRONG CYP3A4 INHIBITORS/EVEROLIMUS
- STRONG CYP3A4 INHIBITORS/MARAVIROC
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- POSSIBLE QT PROLONGING AGENTS/SERTINDOLE
- POSSIBLE QT PROLONGING AGENTS/DROPERIDOL
- POSSIBLE QT PROLONGING AGENTS/LEVOMETHADYL
- POSSIBLE QT PROLONGING AGENTS/SPARFLOXACIN
- POSSIBLE QT PROLONGING AGENTS/HALOFANTRINE
- POSSIBLE QT PROLONGING AGENTS/BEPRIDIL
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR/COLCHICINE
- SELECTED CYP3A4 INHIBITORS/SELECTED OPIOIDS
- QT PROLONGING AGENTS/AMIODARONE
- SELECTED CYP3A4 INHIBITORS/TRAZODONE
- SELECTED AZOLE ANTIFUNGALS/SELECTED VINCA ALKALOIDS
- VORICONAZOLE/SIROLIMUS
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- AZOLE ANTIFUNGALS/SULFONYLUREAS
- SELECTED AZOLE ANTIFUNGALS/BOCEPREVIR; TELAPREVIR
- VORICONAZOLE/SELECTED QT PROLONGING AGENTS
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- STRONG CYP3A4 INHIBITORS/PRALSETINIB
- STRONG CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- STRONG CYP3A4 INHIBITORS/FOSTAMATINIB
- POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
- QT PROLONGING AGENTS/AMISULPRIDE
- STRONG CYP3A4 INHIBITORS/CANNABIDIOL-TETRAHYDROCANNABINOL
- SELECTED STRONG CYP3A4 INHIBITORS/MEFLOQUINE
- STRONG CYP3A4 INHIBITORS/ZANUBRUTINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ILOPERIDONE
- STRONG CYP3A4 INHIBITORS/BREXPIPRAZOLE
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (<= 15 MG)
- STRONG CYP3A4 INHIBITORS/CLONAZEPAM
- STRONG CYP3A4 INHIBITORS/MIDOSTAURIN
- SELECTED CYP3A4 INHIBITORS/BROMOCRIPTINE; CABERGOLINE
- POSSIBLE QT PROLONGING AGENTS/LENVATINIB
- QT PROLONGING AGENTS/CLARITHROMYCIN
- STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (> 15 MG)
- VORICONAZOLE/ATORVASTATIN; FLUVASTATIN
- STRONG CYP3A4 INHIBITORS/REGORAFENIB
- SELECTED MODERATE CYP2C19 INHIBITORS/CLOBAZAM
- POSSIBLE QT PROLONGING AGENTS/ONDANSETRON
- SELECTED CYP2C19 INHIBITORS/CITALOPRAM (<= 20 MG)
- STRONG CYP3A4 INHIBITORS/VARDENAFIL (<=2.5 MG)
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- STRONG CYP3A4 INHIBITORS/PANOBINOSTAT (<= 10 MG)
- POSSIBLE QT PROLONGING AGENTS/SAQUINAVIR
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
- SELECTED AZOLE ANTIFUNGALS/SELECTED CALCIUM CHANNEL BLOCKERS
- SELECTED AZOLE ANTIFUNGALS/GEFITINIB; IMATINIB
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
- POSSIBLE QT PROLONGING AGENTS/THIORIDAZINE
- SELECTED AZOLE ANTIFUNGAL AGENTS/SELECTED CORTICOSTEROIDS
- STRONG CYP3A4 INHIBITORS/BUSPIRONE
- SELECTED AZOLE ANTIFUNGALS/BUSULFAN
- STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
- SELECTED STRONG CYP3A4 INHIBITORS/ARTEMETHER;LUMEFANTRINE
- VORICONAZOLE/OMEPRAZOLE
- SELECTED AZOLE ANTIFUNGALS/FELODIPINE; NISOLDIPINE
- SELECTED CYP2C9 INHIBITORS/SELECTED NSAIDS
- STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
- SELECTED AZOLE ANTIFUNGALS/SELECTED BENZODIAZEPINES
- STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (<=50MG)
- SLT STRONG CYP3A4 INHIBITORS/SILDENAFIL (ED); TADALAFIL (ED)
You Might Also Like
View More
Drug Survey
Are you currently using Vfend IV vial?
This survey is being conducted by the WebMD marketing sciences department.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.